focus trial semaglutide Long-term weight loss effects of in obesity without diabetes in the SELECT Four interesting trials studying semaglutide;

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

However, treating diabetes with GLP-1 hormones resulted in significant side effects, leading researchers financed by Novo Nordisk to start looking to develop a suitable compound for therapeutic use

Chintan Dave, a core faculty member of the Center for Pharmacoepidemiology and Treatment Science at Rutgers Institute for Health, Health Care Policy and Aging Research, told Newsweek that patients should not stop or reconsider GLP-1 medications solely because of this potential risk

When doses are withdrawn use aseptic technique in order to avoid contamination and preserver solution integrity